| 1TQN |
2.05 |
Crystal Structure of Human Microsomal P450 3A4 |
| 1W0E |
2.8 |
Crystal structure of human cytochrome P450 3A4 |
| 1W0F |
2.65 |
Crystal structure of human cytochrome P450 3A4 |
| 1W0G |
2.73 |
Crystal structure of human cytochrome P450 3A4 |
| 2J0D |
2.75 |
Crystal structure of human P450 3A4 in complex with erythromycin |
| 2V0M |
2.8 |
Crystal structure of human P450 3A4 in complex with ketoconazole |
| 3NXU |
2.0 |
Crystal structure of human cytochrome P4503A4 bound to an inhibitor ritonavir |
| 3TJS |
2.25 |
Crystal Structure of the complex between human cytochrome P450 3A4 and desthiazolylmethyloxycarbonyl ritonavir |
| 3UA1 |
2.15 |
Crystal structure of the cytochrome P4503A4-bromoergocryptine complex |
| 4D6Z |
1.93 |
Cytochrome P450 3A4 bound to imidazole and an inhibitor |
| 4D75 |
2.25 |
Cytochrome P450 3A4 bound to an inhibitor |
| 4D78 |
2.8 |
Cytochrome P450 3A4 bound to an inhibitor |
| 4D7D |
2.76 |
Cytochrome P450 3A4 bound to an inhibitor |
| 4I3Q |
2.602 |
Crystal structure of human CYP3A4 coordinated to a water molecule |
| 4I4G |
2.718 |
Crystal structure of CYP3A4 ligated to oxazole-substituted desoxyritonavir |
| 4I4H |
2.9 |
Crystal structure of CYP3A4 ligated to pyridine-substituted desoxyritonavir |
| 4K9T |
2.5 |
Complex of CYP3A4 with a desoxyritonavir analog |
| 4K9U |
2.85 |
Complex of human CYP3A4 with a desoxyritonavir analog |
| 4K9V |
2.6 |
Complex of CYP3A4 with a desoxyritonavir analog |
| 4K9W |
2.399 |
Complex of human CYP3A4 with a desoxyritonavir analog |
| 4K9X |
2.76 |
Complex of human CYP3A4 with a desoxyritonavir analog |
| 4NY4 |
2.95 |
Crystal structure of CYP3A4 in complex with an inhibitor |
| 5A1P |
2.5 |
Crystal structure of cytochrome P450 3A4 bound to progesterone and citrate |
| 5A1R |
2.45 |
Crystal structure of cytochrome P450 3A4 bound to progesterone |
| 5G5J |
2.6 |
Crystal structure of human CYP3A4 bound to metformin |
| 5TE8 |
2.7 |
Crystal structure of the midazolam-bound human CYP3A4 |
| 5VC0 |
2.7 |
Crystal structure of human CYP3A4 bound to ritonavir |
| 5VCC |
1.7 |
Crystal structure of human CYP3A4 bound to glycerol |
| 5VCD |
1.95 |
Crystal structure of the cysteine depleted CYP3A4 bound to glycerol |
| 5VCE |
2.2 |
Crystal structure of the cysteine depleted CYP3A4 bound to ritonavir |
| 5VCG |
2.2 |
Crystal structure of the cysteine depleted CYP3A4 bound to bromoergocryptine |
| 6BCZ |
2.23 |
Crystal structure of human CYP3A4 bound to an inhibitor |
| 6BD5 |
2.5 |
Crystal structure of human CYP3A4 bound to an inhibitor |
| 6BD6 |
2.5 |
Crystal structure of human CYP3A4 bound to an inhibitor |
| 6BD7 |
2.42 |
Crystal structure of human CYP3A4 bound to an inhibitor |
| 6BD8 |
2.38 |
Crystal structure of human CYP3A4 bound to an inhibitor |
| 6BDH |
2.25 |
Crystal structure of human CYP3A4 bound to an inhibitor |
| 6BDI |
2.57 |
Crystal structure of human CYP3A4 bound to an inhibitor |
| 6BDK |
2.67 |
Crystal structure of human CYP3A4 bound to an inhibitor |
| 6BDM |
2.6 |
Crystal structure of human CYP3A4 bound to an inhibitor |
| 6OO9 |
2.25 |
Human CYP3A4 bound to a drug mibefradil |
| 6OOA |
2.52 |
Human CYP3A4 bound to a drug substrate |
| 6OOB |
2.202 |
Human CYP3A4 bound to a suicide substrate |
| 7KS8 |
2.5 |
Crystal structure of human CYP3A4 with the caged inhibitor |
| 7KSA |
2.5 |
Crystal structure of human CYP3A4 with the caged inhibitor |
| 7KVH |
2.791 |
Human CYP3A4 bound to an inhibitor |
| 7KVI |
2.55 |
Human CYP3A4 bound to an inhibitor |
| 7KVJ |
2.65 |
Human CYP3A4 bound to an inhibitor |
| 7KVK |
2.55 |
Human CYP3A4 bound to an inhibitor |
| 7KVM |
2.75 |
Human CYP3A4 bound to an inhibitor |
| 7KVN |
2.7 |
Human CYP3A4 bound to an inhibitor |
| 7KVO |
2.65 |
Human CYP3A4 bound to an inhibitor |
| 7KVP |
2.75 |
Human CYP3A4 bound to an inhibitor |
| 7KVQ |
2.75 |
Human CYP3A4 bound to an inhibitor |
| 7KVS |
2.5 |
Human CYP3A4 bound to an inhibitor |
| 7LXL |
2.75 |
Crystal structure of human CYP3A4 bound to the testosterone dimer |
| 7UAY |
2.78 |
Crystal structure of human CYP3A4 with the caged inhibitor |
| 7UAZ |
2.65 |
Crystal structure of human CYP3A4 with the caged inhibitor |
| 7UF9 |
2.45 |
CYP3A4 bound to an inhibitor |
| 7UFA |
2.5 |
CYP3A4 bound to an inhibitor |
| 7UFB |
2.25 |
CYP3A4 bound to an inhibitor |
| 7UFC |
2.35 |
Human CYP3A4 bound to an inhibitor |
| 7UFD |
2.9 |
Human CYP3A4 bound to an inhibitor |
| 7UFE |
2.4 |
Human CYP3A4 bound to an inhibitor |
| 7UFF |
2.7 |
Human CYP3A4 bound to an inhibitor |
| 8DYC |
2.4 |
Human CYP3A4 bound to a substrate |
| 8EWD |
2.2 |
Crystal structure of CYP3A4 bound to an inhibitor |
| 8EWE |
2.3 |
Crystal structure of CYP3A4 bound to an inhibitor |
| 8EWL |
2.35 |
Crystal structure of CYP3A4 bound to an inhibitor |
| 8EWM |
2.3 |
Crystal structure of CYP3A4 bound to an inhibitor |
| 8EWN |
2.1 |
Crystal structure of CYP3A4 bound to an inhibitor |
| 8EWP |
2.4 |
Crystal structure of CYP3A4 bound to an inhibitor |
| 8EWQ |
2.25 |
Crystal structure of CYP3A4 bound to an inhibitor |
| 8EWR |
2.2 |
Crystal structure of CYP3A4 bound to an inhibitor |
| 8EWS |
2.15 |
Crystal structure of CYP3A4 bound to an inhibitor |
| 8EXB |
2.05 |
Crystal structure of CYP3A4 bound to an inhibitor |
